Showing 1 - 8 results of 8 for search 'Elena S Ratner', query time: 0.04s Refine Results
  1. 1
    Gene expression of non-homologous end-joining pathways in the prognosis of ovarian cancer

    Gene expression of non-homologous end-joining pathways in the prognosis of ovarian cancer by Ethan S. Lavi, Z. Ping Lin, Elena S. Ratner

    Published 2023-10-01
    Get full text
    Article
  2. 2
    Targeting Cyclin-Dependent Kinases for Treatment of Gynecologic Cancers

    Targeting Cyclin-Dependent Kinases for Treatment of Gynecologic Cancers by Z. Ping Lin, Yong-Lian Zhu, Elena S. Ratner

    Published 2018-08-01
    Get full text
    Article
  3. 3
    Opsoclonus-ataxia syndrome and mature ovarian teratoma in an adolescent

    Opsoclonus-ataxia syndrome and mature ovarian teratoma in an adolescent by Emily M. Webster, Joan Tymon-Rosario, Johanna D'Addario, Burak Zeybek, Elena S. Ratner

    Published 2020-08-01
    Get full text
    Article
  4. 4
    Transforming Growth Factor Beta and Epithelial to Mesenchymal Transition Alter Homologous Recombination Repair Gene Expression and Sensitize BRCA Wild-Type Ovarian Cancer Cells to Olaparib

    Transforming Growth Factor Beta and Epithelial to Mesenchymal Transition Alter Homologous Recombination Repair Gene Expression and Sensitize BRCA Wild-Type Ovarian Cancer Cells to... by Cai M. Roberts, Mehida Rojas-Alexandre, Ruth E. Hanna, Z. Ping Lin, Elena S. Ratner

    Published 2023-08-01
    Get full text
    Article
  5. 5
    Combination of triapine, olaparib, and cediranib suppresses progression of BRCA-wild type and PARP inhibitor-resistant epithelial ovarian cancer.

    Combination of triapine, olaparib, and cediranib suppresses progression of BRCA-wild type and PARP inhibitor-resistant epithelial ovarian cancer. by Z Ping Lin, Yong-Lian Zhu, Ying-Chun Lo, Jake Moscarelli, Amy Xiong, Yasmin Korayem, Pamela H Huang, Smith Giri, Patricia LoRusso, Elena S Ratner

    Published 2018-01-01
    Get full text
    Article
  6. 6
    In silico screening identifies a novel small molecule inhibitor that counteracts PARP inhibitor resistance in ovarian cancer

    In silico screening identifies a novel small molecule inhibitor that counteracts PARP inhibitor resistance in ovarian cancer by Z. Ping Lin, Nour N. Al Zouabi, Mark L. Xu, Nicole E. Bowen, Terence L. Wu, Ethan S. Lavi, Pamela H. Huang, Yong-Lian Zhu, Baek Kim, Elena S. Ratner

    Published 2021-04-01
    Get full text
    Article
  7. 7
    Associated characteristics and impact on recurrence and survival of free-floating tumor fragments in the lumen of fallopian tubes in Type I and Type II endometrial cancer

    Associated characteristics and impact on recurrence and survival of free-floating tumor fragments in the lumen of fallopian tubes in Type I and Type II endometrial cancer by Benjamin B. Albright, Jonathan D. Black, Rachel Passarelli, Stefan Gysler, Margaret Whicker, Gary Altwerger, Gulden Menderes, Natalia Buza, Pei Hui, Alessandro D. Santin, Masoud Azodi, Dan-Arin Silasi, Elena S. Ratner, Babak Litkouhi, Peter E. Schwartz

    Published 2018-02-01
    Get full text
    Article
  8. 8
    Prescribed medical cannabis in women with gynecologic malignancies: A single-institution survey-based study

    Prescribed medical cannabis in women with gynecologic malignancies: A single-institution survey-based study by Emily M. Webster, Ghanshyam S. Yadav, Stefan Gysler, Blair McNamara, Jonathan Black, Joan Tymon-Rosario, Burak Zeybek, Chanhee Han, Christopher K. Arkfeld, Vaagn Andikyan, Gulden Menderes, Gloria Huang, Masoud Azodi, Dan-Arin Silasi, Alessandro D. Santin, Peter E. Schwartz, Elena S. Ratner, Gary Altwerger

    Published 2020-11-01
    Get full text
    Article

Search Tools: